选择一个PACC:在阿尔茨海默病研究中比较特定领域和一般认知复合物
Nicole S McKay1, Peter R Millar2, Jessica Nicosia2
1Mallinckrodt Institute of Radiology, Washington University School of Medicine.
Neuropsychology
|April 11, 2024
概括
在预测阿尔茨海默病生物标志物方面,一般认知复合物略好于域特定的复合物. 全球和奈特-PACC复合剂需要更小的样本大小进行临床试验.
科学领域:
- 神经科学是一个神经科学.
- 认知心理学 认知心理学
- 生物标志物研究 生物标志物研究
背景情况:
- 阿尔茨海默病 (AD) 研究需要强大的认知评估.
- 现有的认知复合材料可能无法完全捕获复杂的认知数据.
- 开发多功能认知复合材料对于AD研究至关重要.
研究的目的:
- 从复杂的数据中演示域特定和一般认知复合物的创建.
- 评估这些复合材料在阿尔茨海默病研究中的有用性.
- 为了比较不同类型的复合材料对AD生物标志物的预测能力.
主要方法:
- 使用 equipercentile 方程来结合多次代的统一数据集数据.
- 进行探索性因子分析,以获得特定领域的复合物 (情节记忆,语义记忆,工作记忆,注意力/处理速度).
- 计算了临床前阿尔茨海默病认知复合物 (PACC),Knight-PACC,以及用于生物标志物预测分析的全球复合物.
主要成果:
- 一般认知复合材料在预测粉样蛋白,蛋白和神经退行负担方面比域特定复合材料略有优势.
- 功率分析表明,全球,Knight-PACC和注意力/处理速度复合物需要更小的样本大小进行临床试验.
- 阿尔茨海默病合作研究-PACC复合物需要比其他复合物大两到三倍的样本大小.
结论:
- 使用Knight-PACC和特定领域复合物的认知分析为研究人员提供了灵活性.
- 经过验证的结果评估可以将各种研究问题的测试版本等同起来.
- 这些复合材料有助于理解正常衰老和神经退行性疾病中的认知衰退.
更多相关视频
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
32.3K
11:01Examining the Characteristics of Episodic Memory using Event-related Potentials in Patients with Alzheimer's Disease
Published on: August 30, 2011
13.6K
相关概念视频
01:26Alzheimer's Disease: Overview
468
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
468
01:30Dementia
113
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
113
01:30Cognitive Development During Adulthood
94
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
94
01:22Alzheimer's Disease: Treatment
183
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
183